Home/Filings/4/0001384101-25-000021
4//SEC Filing

McGuire Annie 4

Accession 0001384101-25-000021

CIK 0001384101other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:29 PM ET

Size

8.7 KB

Accession

0001384101-25-000021

Insider Transaction Report

Form 4
Period: 2025-02-27
McGuire Annie
SVP, General Counsel
Transactions
  • Award

    Common Stock

    2025-02-27+13,46686,705 total
  • Tax Payment

    Common Stock

    2025-03-02$34.76/sh8,255$286,94471,450 total
  • Tax Payment

    Common Stock

    2025-02-27$33.84/sh7,000$236,88079,705 total
Footnotes (4)
  • [F1]Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein.
  • [F2]Includes 370 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
  • [F3]Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
  • [F4]The reporting person is reporting the withholding of 726, 453, 743 and 6,333 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429, 892, 1,463 and 12,470 Restricted Stock Units granted on February 28, 2022, August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001914620

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:29 PM ET
Size
8.7 KB